BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28387670)

  • 1. Angiotensin-III is Increased in Alzheimer's Disease in Association with Amyloid-β and Tau Pathology.
    Kehoe PG; Hibbs E; Palmer LE; Miners JS
    J Alzheimers Dis; 2017; 58(1):203-214. PubMed ID: 28387670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-β and tau pathology.
    Kehoe PG; Wong S; Al Mulhim N; Palmer LE; Miners JS
    Alzheimers Res Ther; 2016 Nov; 8(1):50. PubMed ID: 27884212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal Fluid Changes in the Renin-Angiotensin System in Alzheimer's Disease.
    Kehoe PG; Al Mulhim N; Zetterberg H; Blennow K; Miners JS
    J Alzheimers Dis; 2019; 72(2):525-535. PubMed ID: 31594235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release.
    Zini S; Fournie-Zaluski MC; Chauvel E; Roques BP; Corvol P; Llorens-Cortes C
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11968-73. PubMed ID: 8876246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer's disease: Past, present and future.
    Gouveia F; Camins A; Ettcheto M; Bicker J; Falcão A; Cruz MT; Fortuna A
    Ageing Res Rev; 2022 May; 77():101612. PubMed ID: 35346852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of ACE-1 in Normal Aging and the Early Stages of Alzheimer's Disease.
    MacLachlan R; Kehoe PG; Miners JS
    J Gerontol A Biol Sci Med Sci; 2022 Sep; 77(9):1775-1783. PubMed ID: 35396835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal Fluid Levels of Angiotensin-Converting Enzyme Are Associated with Amyloid-β42 Burden in Alzheimer's Disease.
    Rocha NP; Toledo A; Corgosinho LTS; de Souza LC; Guimarães HC; Resende EPF; Braz NFT; Gomes KB; Simoes E Silva AC; Caramelli P; Teixeira AL
    J Alzheimers Dis; 2018; 64(4):1085-1090. PubMed ID: 30040721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The angiotensin 1-converting enzyme insertion (I)/deletion (D) polymorphism does not influence the extent of amyloid or tau pathology in patients with sporadic Alzheimer's disease.
    Lendon CL; Thaker U; Harris JM; McDonagh AM; Lambert JC; Chartier-Harlin MC; Iwatsubo T; Pickering-Brown SM; Mann DM
    Neurosci Lett; 2002 Aug; 328(3):314-8. PubMed ID: 12147333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyroglutamylated amyloid-β is associated with hyperphosphorylated tau and severity of Alzheimer's disease.
    Mandler M; Walker L; Santic R; Hanson P; Upadhaya AR; Colloby SJ; Morris CM; Thal DR; Thomas AJ; Schneeberger A; Attems J
    Acta Neuropathol; 2014 Jul; 128(1):67-79. PubMed ID: 24861310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher Angiotensin II Type 1 Receptor Levels and Activity in the Postmortem Brains of Older Persons with Alzheimer's Dementia.
    Cosarderelioglu C; Nidadavolu LS; George CJ; Marx-Rattner R; Powell L; Xue QL; Tian J; Salib J; Oh ES; Ferrucci L; Dincer P; Bennett DA; Walston JD; Abadir PM
    J Gerontol A Biol Sci Med Sci; 2022 Apr; 77(4):664-672. PubMed ID: 34914835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of the renin-angiotensin system in vascular dementia.
    Tayler HM; Skrobot OA; Baron DH; Kehoe PG; Miners JS
    Brain Pathol; 2024 Mar; 34(4):e13251. PubMed ID: 38454306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel role of aminopeptidase-A in angiotensin-(1-7) metabolism post myocardial infarction.
    Alghamri MS; Morris M; Meszaros JG; Elased KM; Grobe N
    Am J Physiol Heart Circ Physiol; 2014 Apr; 306(7):H1032-40. PubMed ID: 24464749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of dietary cholesterol on aminopeptidase A, B and M in the frontal cortex of male and female mice.
    Ramírez-Expósito MJ; García MJ; Mayas MD; Ramírez M; Martínez-Martos JM
    Nutr Neurosci; 2001; 4(6):461-8. PubMed ID: 11843265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.
    Tayler H; Fraser T; Miners JS; Kehoe PG; Love S
    J Alzheimers Dis; 2010; 22(4):1363-73. PubMed ID: 20930272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-Angiotensin System Alterations in the Human Alzheimer's Disease Brain.
    Ismael S; Mirzahosseini G; Ahmed HA; Yoo A; Kassan M; Malik KU; Ishrat T
    J Alzheimers Dis; 2021; 84(4):1473-1484. PubMed ID: 34690145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Level and Significance of Circulating Angiotensin-III in Patients with Coronary Atherosclerosis.
    Yao G; Li W; Liu W; Xing J; Zhang C
    J Renin Angiotensin Aldosterone Syst; 2021; 2021():1704762. PubMed ID: 34603502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain ACE2 activation following brain aminopeptidase A blockade by firibastat in salt-dependent hypertension.
    Hmazzou R; Marc Y; Flahault A; Gerbier R; De Mota N; Llorens-Cortes C
    Clin Sci (Lond); 2021 Mar; 135(6):775-791. PubMed ID: 33683322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
    Herline K; Prelli F; Mehta P; MacMurray C; Goñi F; Wisniewski T
    Alzheimers Res Ther; 2018 Jun; 10(1):54. PubMed ID: 29914551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
    Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
    Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin receptor blocker use is associated with upregulation of the memory-protective angiotensin type 4 receptor (AT
    Cosarderelioglu C; Nidadavolu LS; George CJ; Marx-Rattner R; Powell L; Xue QL; Tian J; Oh ES; Ferrucci L; Dincer P; Bennett DA; Walston JD; Abadir PM
    Geroscience; 2023 Feb; 45(1):371-384. PubMed ID: 35969296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.